US Patent 10626187 Antigen binding molecules specific for an anti-CD19 scFv
Patent 10626187 was granted and assigned to Kite Pharma, Inc. on April, 2020 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10626187 Antigen binding molecules specific for an anti-CD19 scFv
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
